Drug Trial Radar · NCT07522606
Compassionate Use for BIA 28-6156 in Patients With Parkinson's Disease (PD) Who Have a Pathogenic Variant in the GBA1 Gene (GBA-PD) and Completed the ACTIVATE Study
Last checked: Nov 20, 2026Latest source record: Aug 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
No longer available
Enrollment
Not stated
Start
Not stated
Primary completion
Not stated
Sponsor
- Lead sponsor
- Bial R&D Investments, S.A.Industry
- Sponsor type
- Industry
- First posted
- Apr 13, 2026
Design
- Study type
- Expanded access
- Who can join
- All sexes
Summary
As written by the sponsor on the registry.
This Program is designed to provide continued access BIA 28-6156, free and compassionately for an eligible patient previously enrolled in the BIA 28-6156-201 (ACTIVATE) clinical study and that had completed the study.
Conditions
- Parkinson Disease
Interventions
BIA 28-6156Drug
60mg dosage of BIA 28-6156 taken orally once daily
Primary outcomes
What the sponsor says the trial is designed to measure.
No primary outcomes listed.
Locations
36 sites in 5 countries. Site status is shown where the registry gives one.
Barrow Neurological Institute
Phoenix, Arizona
University of Colorado
Aurora, Colorado
Parkinson's Center and Movement Disorders of Boca Raton
Boca Raton, Florida
University of Miami, Dept. of Neurology
Miami, Florida
Northwestern University
Chicago, Illinois
University of Kansas Medical Center
Kansas City, Kansas
University of Kentucky
Lexington, Kentucky
University of Maryland Medical Center
Baltimore, Maryland
Massachusetts General Hospital
Boston, Massachusetts
Park Nicollet Struther's Parkinson's Center (Struthers Parkinsons Center at HealthPartners)
Saint Paul, Minnesota
Cleveland Clinic Foundation
Cleveland, Ohio
MUSC
Charleston, South Carolina
Vanderbilt Medical Center
Nashville, Tennessee
Intermountain Healthcare
Salt Lake City, Utah
University of Washington
Seattle, Washington
Inland Northwest Research
Spokane, Washington
IRCCS Istituto Delle Scienze Neurologiche DI
Bologna, Italy
Spedali Civilia di Brescia
Brescia, Italy
Ospedale Antonio Perrino
Brindisi, Italy
Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico
Milan, Italy
Universita degli Studi della Campania Luigi Vanvitelli - Clinica Neurologia I
Naples, Italy
Universita degli Studi di Padova - Azienda Ospedaliera di Padova - Clinica Neurologica
Padova, Italy
IRCSS San Raffaele Pisana
Roma, Italy
A.O.U. San Giovanni di Dio Ruggi d'Aragona Centro Parkinson- Piano Rialzato Corpo QT
Salerno, Italy
Hospital Senhora da Oliveira de Guimaraes
Guimarães, Portugal
Hospital Universitari Germans Trias i Pujol
Badalona, Spain
Hospital Universitario Cruces
Barakaldo, Spain
Hospital de la Santa Creu I Sant Pau
Barcelona, Spain
Hospital Vall D´Hebron
Barcelona, Spain
Hospital Universitaio de La Princesa
Madrid, Spain
Hospital Ruber Internacional
Madrid, Spain
Hospital Universitario Virgen del Rocio
Seville, Spain
NHS Tayside-Ninewells Hospital and Medical School
Dundee, United Kingdom
King's College London - David Goldberg Centre
London, United Kingdom
The Newcastle upon Tyne Hospitals NHS Foundation Trust, Freeman Hospital
Newcastle upon Tyne, United Kingdom
University Hospitals Plymouth NHS Trust
Plymouth, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.